サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1468232

EPA・DHAの市場レポート：タイプ、供給源、用途、地域別、2024年～2032年

EPA & DHA Market Report by Type (Eicosapentaenoic Acid, Docosahexaenoic Acid ), Source, Application, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
EPA・DHAの市場レポート：タイプ、供給源、用途、地域別、2024年～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のEPA・DHA市場規模は2023年に18億7,740万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに32億2,880万米ドルに達し、2024年から2032年の間に6.02%の成長率（CAGR）を示すと予測しています。オメガ3脂肪酸の健康効果に対する消費者の意識の高まり、機能性食品やサプリメントに対する需要の高まり、漁業における持続可能で環境に優しい調達方法の普及が、市場を牽引する主な要因のいくつかです。

EPA（エイコサペンタエン酸）とDHA（ドコサヘキサエン酸）は、類似した化学構造を持つ長鎖多価不飽和オメガ3脂肪酸を指し、人間の健康に不可欠です。通常、サケ、サバ、イワシ、藻類などの脂肪分の多い魚に含まれるEPA・DHAは、人間の体内では合成されないため、食事やサプリメントから摂取する必要があります。魚やサプリメントから摂取したEPAやDHAは生物学的利用能が高いため、人体に比較的容易に吸収され、細胞膜など必要な構造物に取り込まれます。EPA・DHAは認知機能の低下を防ぎ、抗炎症作用により心臓病、コレステロール、関節炎などの慢性疾患のリスクを軽減するため、脳の機能と発達に重要です。このほか、EPA・DHAは免疫系の調整、皮膚の健康、加齢黄斑変性症のリスクの最小化にも重要です。

EPA・DHAの市場動向：

世界市場は、EPA・DHAを含有するサプリメントや機能性食品に対する需要の高まりが主な要因となっています。これは、大衆、特に老年人口の間で心臓病、糖尿病、がんなどの慢性疾患の罹患率が上昇していることに起因しています。これに伴い、健康やフィットネスに対する消費者の意識が高まっていることも、EPAやDHA強化食品の需要を後押ししています。さらに、乳児用調製粉乳やペットフードにおけるEPA・DHAの使用量の増加が、市場に有利な成長機会を生み出しています。このほか、製造業者が高純度・高濃度のEPA・DHAサプリメントや機能性食品を製造できるようにする加工技術の継続的な進歩も、市場に弾みをつけています。消費者の間で植物ベースの菜食主義が広まりつつあることから、藻類ベースのサプリメントや食品など、植物ベースのEPAおよびDHA供給源の利用が増加しています。市場は、食品やサプリメントに関する規制や表示要件のパラダイムシフトによってさらに活性化され、その結果、企業は新しい規則に準拠するために処方やマーケティング戦略を調整しています。市場に寄与するその他の要因としては、急速な都市化、水産業における持続可能で環境に優しい調達慣行の普及、可処分所得水準の上昇、主要企業による広範な研究開発活動などが挙げられます。

本レポートで扱う主な質問

  • 世界のEPA &DHA市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界のEPA &DHA市場における促進要因、抑制要因、機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界のEPA &DHA市場に与える影響は？
  • 主要な地域市場は？
  • 最も魅力的なEPA &DHA市場を代表する国は？
  • タイプ別の市場内訳は？
  • EPA・DHA市場で最も魅力的なタイプは？
  • 供給源別の市場内訳は？
  • EPA・DHA市場で最も魅力的な供給源は？
  • 用途別の市場内訳は？
  • EPA・DHA市場で最も魅力的な用途は？
  • 世界のEPA &DHA市場の競争構造は？
  • 世界のEPA &DHA市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のEPA・DHA市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • エイコサペンタエン酸（EPA）
    • 市場動向
    • 市場予測
  • ドコサヘキサエン酸（DHA）
    • 市場動向
    • 市場予測

第7章 市場内訳：供給源別

  • 魚油
    • 市場動向
    • 市場予測
  • 藻類油
    • 市場動向
    • 市場予測
  • クリルオイル
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 乳児用調製粉乳
    • 市場動向
    • 市場予測
  • 栄養補助食品
    • 市場動向
    • 市場予測
  • 強化食品と飲食品
    • 市場動向
    • 市場予測
  • 医薬品
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AlgiSy BioSciences Inc.
    • Arctic Nutrition AG
    • BASF SE
    • Biosearch Sau
    • Corbion NV
    • Croda International PLC
    • KD Pharma Group
    • Koninklijke DSM NV
    • Nordic Naturals Inc
    • Novasep Holding SAS
    • Novotech Nutraceuticals Inc
    • Omega Protein Corporation
    • Polaris
図表

List of Figures

  • Figure 1: Global: EPA & DHA Market: Major Drivers and Challenges
  • Figure 2: Global: EPA & DHA Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: EPA & DHA Market: Breakup by Type (in %), 2023
  • Figure 5: Global: EPA & DHA Market: Breakup by Source (in %), 2023
  • Figure 6: Global: EPA & DHA Market: Breakup by Application (in %), 2023
  • Figure 7: Global: EPA & DHA Market: Breakup by Region (in %), 2023
  • Figure 8: Global: EPA & DHA (Eicosapentaenoic Acid (EPA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: EPA & DHA (Eicosapentaenoic Acid (EPA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: EPA & DHA (Docosahexaenoic Acid (DHA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: EPA & DHA (Docosahexaenoic Acid (DHA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: EPA & DHA (Fish Oil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: EPA & DHA (Fish Oil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: EPA & DHA (Algae Oil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: EPA & DHA (Algae Oil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: EPA & DHA (Krill Oil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: EPA & DHA (Krill Oil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: EPA & DHA (Other Sources) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: EPA & DHA (Other Sources) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: EPA & DHA (Infant Formulae) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: EPA & DHA (Infant Formulae) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: EPA & DHA (Dietary Supplements) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: EPA & DHA (Dietary Supplements) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: EPA & DHA (Fortified Food and Beverages) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: EPA & DHA (Fortified Food and Beverages) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: EPA & DHA (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: EPA & DHA (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: EPA & DHA (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: EPA & DHA (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: EPA & DHA Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: EPA & DHA Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: EPA & DHA Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: EPA & DHA Industry: Drivers, Restraints, and Opportunities
  • Figure 80: Global: EPA & DHA Industry: Value Chain Analysis
  • Figure 81: Global: EPA & DHA Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: EPA & DHA Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: EPA & DHA Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: EPA & DHA Market Forecast: Breakup by Source (in Million US$), 2024-2032
  • Table 4: Global: EPA & DHA Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: EPA & DHA Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: EPA & DHA Market: Competitive Structure
  • Table 7: Global: EPA & DHA Market: Key Players
目次
Product Code: SR112024A7339

The global EPA & DHA market size reached US$ 1,877.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,228.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032. The increasing consumer awareness about the health benefits of omega-3 fatty acids, rising demand for functional foods and supplements, and the growing prevalence of sustainable and eco-friendly sourcing practices in the fishing industry represent some of the key factors driving the market.

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) refer to long-chain polyunsaturated omega-3 fatty acids with similar chemical structures that are essential for human health. Usually found in fatty fish, such as salmon, mackerel, sardines and algae, EPA and DHA are not synthesized by the human body and must be obtained through diet or supplementation. EPA and DHA from fish and supplements are highly bioavailable, therefore they are absorbed by the human body relatively easily and can be incorporated into cell membranes and other structures where they are needed. EPA and DHA are important for brain function and development as they protect against cognitive decline and their anti-inflammatory properties help to reduce the risk of chronic diseases, such as heart disease, cholesterol, and arthritis. In addition to this, EPA and DHA are important for regulating the immune system, benefitting skin health and minimizing the risks of age-related macular degeneration.

EPA & DHA Market Trends:

The global market is majorly driven by the augmenting demand for supplements and functional foods containing EPA and DHA. This can be attributed to the rising incidences of chronic diseases, such as heart disease, diabetes, and cancer among the masses, particularly the geriatric population. In line with this, the increasing awareness among consumers regarding health and fitness is also propelling the demand for EPA and DHA fortified foods. Moreover, the increasing usage of EPA and DHA in infant formula and pet food is creating lucrative growth opportunities in the market. Besides this, continual technological advancements in the processing techniques enabling manufacturers to produce high-purity and high-concentration EPA and DHA supplements and functional foods are providing an impetus to the market. The growing adoption of plant-based vegan diets among the consumer base is resulting in a higher uptake of plant-based sources of EPA and DHA, such as algae-based supplements and foods. The market is further fueled by the paradigm shift in regulations and labeling requirements for food and supplements, resulting in companies adjusting their formulations and marketing strategies to comply with new rules. Some of the other factors contributing to the market include rapid urbanization, growing prevalence of sustainable and eco-friendly sourcing practices in the fishing industry, inflating disposable income levels, and extensive research and development (R&D) activities conducted by the key players.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global EPA & DHA market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, source and application.

Type Insights:

Eicosapentaenoic Acid (EPA)

Docosahexaenoic Acid (DHA)

The report has provided a detailed breakup and analysis of the EPA & DHA market based on the type. This includes Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA). According to the report, Docosahexaenoic Acid (DHA) represented the largest segment.

Source Insights:

Fish Oil

Algae Oil

Krill Oil

Others

The report has provided a detailed breakup and analysis of the EPA & DHA market based on the source. This includes fish oil, algae oil, krill oil, and others. According to the report, fish oil represented the largest segment.

Application Insights:

Infant Formulae

Dietary Supplements

Fortified Food and Beverages

Pharmaceuticals

Others

A detailed breakup and analysis of the EPA & DHA market based on the application has also been provided in the report. This includes infant formulae, dietary supplements, fortified food and beverages, pharmaceuticals, and others. According to the report, dietary supplements accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for EPA & DHA. Some of the factors driving the Asia Pacific EPA & DHA market included the growing geriatric population, continual technological advancements in sustainable fishing practices, increasing awareness regarding health and fitness, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global EPA & DHA market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AlgiSy BioSciences Inc., Arctic Nutrition AG, BASF SE, Biosearch Sau, Corbion NV, Croda International PLC, KD Pharma Group, Koninklijke DSM NV, Nordic Naturals Inc, Novasep Holding SAS, Novotech Nutraceuticals Inc, Omega Protein Corporation, Polaris, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global EPA & DHA market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global EPA & DHA market?
  • What is the impact of each driver, restraint, and opportunity on the global EPA & DHA market?
  • What are the key regional markets?
  • Which countries represent the most attractive EPA & DHA market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the EPA & DHA market?
  • What is the breakup of the market based on the source?
  • Which is the most attractive source in the EPA & DHA market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the EPA & DHA market?
  • What is the competitive structure of the global EPA & DHA market?
  • Who are the key players/companies in the global EPA & DHA market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global EPA & DHA Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Eicosapentaenoic Acid (EPA)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Docosahexaenoic Acid (DHA)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Fish Oil
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Algae Oil
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Krill Oil
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infant Formulae
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Dietary Supplements
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Fortified Food and Beverages
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pharmaceuticals
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AlgiSy BioSciences Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Arctic Nutrition AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BASF SE
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Biosearch Sau
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Corbion NV
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Croda International PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 KD Pharma Group
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Koninklijke DSM NV
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Nordic Naturals Inc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Novasep Holding SAS
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Novotech Nutraceuticals Inc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 SWOT Analysis
    • 14.3.12 Omega Protein Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Polaris
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.